Alzheimer's blood test may show who's likely to develop it in 5 to 10 years
A blood test may predict if apparently healthy older adults are likely to develop Alzheimer's symptoms in the next five or 10 years, researchers say.
Watch CBS News
A blood test may predict if apparently healthy older adults are likely to develop Alzheimer's symptoms in the next five or 10 years, researchers say.
Sacramento's skyline changed colors on Monday night. The capital city is one of 1,500 sites across the nation turning teal to bring attention to Alzheimer's disease, which now impacts more than 7 million Americans.
Ahead of Solano County's Walk to End Alzheimer's Saturday morning in Fairfield, one Rio Vista man reflects on how the meaning behind the walks has changed for him in recent years.
Japan-based Fujirebio's test, which helps doctors diagnose Alzheimer's disease, is intended for patients with signs of cognitive decline.
Cissy Houston performed alongside superstar musicians like Elvis Presley and Aretha Franklin.
With nearly seven million people currently living with Alzheimer's in the US, advocates stress the urgency of finding a cure, especially as that number is expected to double by 2050.
FDA approval of the new Alzheimer's treatment, which will be branded as Kisunla, follows years of setbacks.
The Bay Area is where it all began for the former San Francisco Giants 1st-round pick Hunter Bishop. However, Bishop's path to professional ball was anything but normal.
Nearly 7 million Americans live with Alzheimer's, a disease that's not only tough on the patient but also on their family. CBS13 has one family's story and message they have for others going through the same thing.
Scientists studying a Colombian family plagued by early-in-life Alzheimer's have found a rare gene variant that seems to delay initial symptoms by about five years.
One father-and-son duo serves as a reminder to pause and simply soak it all in because so quickly the dynamic can change when a parent is diagnosed with dementia.
You've heard of Alzheimer's disease, but do you know how to spot it in a loved one or what to do after a diagnosis?
A resident of Sacramento County's Rosemont community is defying the odds of a debilitating disease with an unexpected approach.
Is the glass half empty or half full? The way you answer the question could reveal your odds of getting Alzheimer's disease.
CBS 13's Marlee Ginter served as emcee for the Walk to End Alzheimer's, which returned to Sacramento on Saturday to raise money to fight Alzheimer's disease and dementia.
The Walk To End Alzheimer's in Sacramento kicks off Saturday morning. Its goal is to raise money to fight Alzheimer's and dementia.
More than 1500 people have registered to attend the Walk to End Alzheimer's event next week, which will raise money to fight Alzheimer's disease as well as Dementia.
Bad air from wildfires or agriculture were most strongly linked to dementia risk.
Medicare could shell out more than $100,000 a year per patient to cover the drug and the complex scans and tests needed to monitor its potentially lethal risks for patients.
Eli Lilly's experimental Alzheimer's drug donanemab can modestly slow the worsening of the disease by about four to seven months, according to researchers.
For the first time, doctors have a medicine to prescribe that has been proven to slow the loss of memory and ability to do daily tasks that Alzheimer's brings.
Even with Medicare coverage, many seniors will be on the hook for a hefty co-payment for the newly approved drug.
Leqembi is not a cure, but it is the first drug shown to slow the progression of Alzheimer's disease. It first received an accelerated approval from the FDA earlier this year.
Leqembi is the first drug that's been shown to slow the progression of Alzheimer's disease.
Shares of the pharmaceutical company jumped almost 5% after announcing promising results for donanemab.
